Barricaid
Woburn
About Barricaid
Barricaid develops a bone-anchored implant that reduces the incidence of reherniation and reoperation in patients with large annular defects. It is designed to prevent reherniation by physically blocking the annulus at the post-surgery defect. The anchor component is comprised of titanium alloy that is placed into either the caudal or cranial-adjacent vertebral body to secure the device in position.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $311.3M
- Last round: Series Unknown (Dec 2023)
- Website: barricaid.com
- Phone: (781)932-0222
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/barricaid-71363 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.